Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F21NL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $63,127
Award facts
- Contract value 100% obligated
- $63,127.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 29, 2026, the Defense Logistics Agency awarded a $63,127.36 delivery order to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. The contract, which operates under a firm fixed-price structure with no set-aside designation, is scheduled for completion by January 30, 2026, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.999 billion through December 2026, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's contract portfolio with DLA demonstrates its capability to supply a comprehensive range of pharmaceutical products across multiple therapeutic domains on a competitively awarded basis. The supply of Biktarvy, an antiretroviral medication used in HIV treatment, reflects the company's role in delivering specialized pharmaceutical commodities essential to military treatment facilities and federal healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26F21NL?
SPE2DR26F21NL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F21NL worth?
The government has obligated $63,127 on SPE2DR26F21NL.
Is contract SPE2DR26F21NL an order under another contract?
Yes. SPE2DR26F21NL is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F21NL competed?
The extent of competition for SPE2DR26F21NL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award